Merck & Co., Inc. (NYSE:MRK) is highlighted among blue-chip stocks with low PE ratios, boasting a forward PE ratio of 11.19. Its robust financial performance, especially in oncology and vaccines, positions it as a stable investment option amidst market fluctuations.